A new trading day began on Friday, with Mind Medicine Inc (NASDAQ: MNMD) stock price down -3.73% from the previous day of trading, before settling in for the closing price of $6.43. MNMD’s price has ranged from $5.03 to $12.22 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Meanwhile, its annual earnings per share averaged 36.90%. With a float of $74.09 million, this company’s outstanding shares have now reached $75.37 million.
Let’s determine the extent of company efficiency that accounts for 74 employees. In terms of profitability, gross margin is 0.0%, operating margin of 0.0%, and the pretax margin is 0.0%.
Mind Medicine Inc (MNMD) Breakdown of a Key Holders of the stock
As we move forward, let’s examine how large-scale investors are investing in this stock of the Biotechnology Industry. The insider ownership of Mind Medicine Inc is 1.20%, while institutional ownership is 49.60%. The most recent insider transaction that took place on Mar 25 ’25, was worth 142,942. In this transaction Chief Executive Officer of this company sold 21,208 shares at a rate of $6.74, taking the stock ownership to the 856,556 shares. Before that another transaction happened on Mar 25 ’25, when Company’s Chief Medical Officer sold 6,836 for $6.74, making the entire transaction worth $46,075. This insider now owns 446,177 shares in total.
Mind Medicine Inc (MNMD) Recent Fiscal highlights
Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.39 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 36.90% per share during the next fiscal year.
Mind Medicine Inc (NASDAQ: MNMD) Trading Performance Indicators
Here are Mind Medicine Inc’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 7.00.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.54, a number that is poised to hit -0.37 in the next quarter and is forecasted to reach -1.77 in one year’s time.
Technical Analysis of Mind Medicine Inc (MNMD)
Looking closely at Mind Medicine Inc (NASDAQ: MNMD), its last 5-days average volume was 1.18 million, which is a drop from its year-to-date volume of 2.01 million. As of the previous 9 days, the stock’s Stochastic %D was 26.13%. Additionally, its Average True Range was 0.48.
During the past 100 days, Mind Medicine Inc’s (MNMD) raw stochastic average was set at 8.61%, which indicates a significant decrease from 21.10% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 35.43% in the past 14 days, which was lower than the 88.87% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $7.19, while its 200-day Moving Average is $7.03. However, in the short run, Mind Medicine Inc’s stock first resistance to watch stands at $6.42. Second resistance stands at $6.65. The third major resistance level sits at $6.81. If the price goes on to break the first support level at $6.03, it is likely to go to the next support level at $5.87. Now, if the price goes above the second support level, the third support stands at $5.64.
Mind Medicine Inc (NASDAQ: MNMD) Key Stats
With a market capitalization of 466.53 million, the company has a total of 75,368K Shares Outstanding. Currently, annual sales are 0 K while annual income is -108,680 K. The company’s previous quarter sales were 0 K while its latest quarter income was -34,740 K.
